Stockscreener 앱 받기
4.78
0.62%
-0.03
시간 외 거래:
4.81
0.03
+0.63%
전일 마감가:
$4.81
열려 있는:
$4.79
하루 거래량:
1.29M
Relative Volume:
1.26
시가총액:
$245.11M
수익:
-
순이익/손실:
$-54.19M
주가수익비율:
-1.8527
EPS:
-2.58
순현금흐름:
$-37.34M
1주 성능:
-13.72%
1개월 성능:
-11.65%
6개월 성능:
-27.13%
1년 성능:
-23.52%
1일 변동 폭
$4.655
$4.855
1주일 범위
$4.655
$5.54
52주 변동 폭
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
명칭
Abeona Therapeutics Inc
전화
646-813-4701
주소
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
ABEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.78 | 246.65M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-03-05 | 개시 | Oppenheimer | Outperform |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-30 | 개시 | Stifel | Buy |
| 2020-11-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-02-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-10 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-08-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2019-08-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2018-10-12 | 개시 | Mizuho | Buy |
| 2018-06-05 | 개시 | Seaport Global Securities | Buy |
| 2017-11-08 | 개시 | SunTrust | Buy |
| 2017-10-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-10-10 | 개시 | Citigroup | Buy |
| 2017-10-05 | 재확인 | Maxim Group | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-07-18 | 재확인 | Maxim Group | Buy |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2017-01-06 | 개시 | Jefferies | Buy |
| 2016-09-29 | 재확인 | Maxim Group | Buy |
모두보기
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
How Abeona Therapeutics Inc. stock reacts to job market dataCPI Data & Low Volatility Stock Recommendations - newser.com
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors favor Abeona Therapeutics Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees - GuruFocus
Sector ETF performance correlation with Abeona Therapeutics Inc.Weekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics (NASDAQ: ABEO) grants 71,035 restricted shares to 11 new employees - Stock Titan
Will Abeona Therapeutics Inc. stock benefit from green energy trendsRisk Management & Precise Buy Zone Tips - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.July 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownMarket Risk Summary & Capital Protection Trade Alerts - newser.com
How Abeona Therapeutics Inc. stock reacts to inflationary pressuresSwing Trade & AI Driven Stock Price Forecasts - newser.com
Should I hold or sell Abeona Therapeutics Inc. stock in 2025Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flow2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Is Abeona Therapeutics Inc. stock oversold or undervaluedWeekly Stock Recap & Weekly Setup with ROI Potential - newser.com
Applying big data sentiment scoring on Abeona Therapeutics Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
How dovish Fed policy supports Abeona Therapeutics Inc. (PCJ) stockPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
CMS assigns permanent J-code for Abeona’s RDEB therapy ZEVASKYN By Investing.com - Investing.com Australia
Can Abeona Therapeutics Inc. stock sustain institutional interestTrade Analysis Report & Community Consensus Trade Signals - newser.com
Is Abeona Therapeutics Inc. stock positioned for long term growthQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidateQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Published on: 2025-10-31 02:43:41 - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock could outperform next yearWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo! Finance UK
Abeona Therapeutics Inc. (PCJ.F) stock price, news, quote and history - Yahoo! Finance Singapore
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy - MarketScreener
Abeona Therapeutics Inc. Announces Permanent J-Code for ZEVASKYN® (prademagene Zamikeracel) - MarketScreener
Abeona Therapeutics announces permanent J-code for Zevaskyn (prademagene zamikeracel) - MarketScreener
Abeona Therapeutics Inc (ABEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):